210 related articles for article (PubMed ID: 31801948)
21. Cell cycle regulation and differentiation in the human podocyte lineage.
Nagata M; Nakayama K; Terada Y; Hoshi S; Watanabe T
Am J Pathol; 1998 Nov; 153(5):1511-20. PubMed ID: 9811343
[TBL] [Abstract][Full Text] [Related]
22. Rituximab protects podocytes and exerts anti-proteinuric effects in rat adriamycin-induced nephropathy independent of B-lymphocytes.
Takahashi Y; Ikezumi Y; Saitoh A
Nephrology (Carlton); 2017 Jan; 22(1):49-57. PubMed ID: 26833819
[TBL] [Abstract][Full Text] [Related]
23. IP
Xu H; Guan N; Ren YL; Wei QJ; Tao YH; Yang GS; Liu XY; Bu DF; Zhang Y; Zhu SN
BMC Nephrol; 2018 Jun; 19(1):140. PubMed ID: 29907098
[TBL] [Abstract][Full Text] [Related]
24. Not too much, not too little-just the right amount: the story of YAP in the podocyte.
McEvoy CM; Yuen DA
Kidney Int; 2024 Jun; 105(6):1157-1159. PubMed ID: 38777398
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation.
Shankland SJ; Eitner F; Hudkins KL; Goodpaster T; D'Agati V; Alpers CE
Kidney Int; 2000 Aug; 58(2):674-83. PubMed ID: 10916090
[TBL] [Abstract][Full Text] [Related]
26. Resolvin D1 protects podocytes in adriamycin-induced nephropathy through modulation of 14-3-3β acetylation.
Zhang X; Qu X; Sun YB; Caruana G; Bertram JF; Nikolic-Paterson DJ; Li J
PLoS One; 2013; 8(6):e67471. PubMed ID: 23840712
[TBL] [Abstract][Full Text] [Related]
27. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats.
Yang W; Wang J; Shi L; Yu L; Qian Y; Liu Y; Wang W; Cheng S
Cytokine; 2012 Aug; 59(2):370-6. PubMed ID: 22579701
[TBL] [Abstract][Full Text] [Related]
28. Macrophage migration inhibitory factor regulates integrin-β1 and cyclin D1 expression via ERK pathway in podocytes.
Chen CA; Chang JM; Yang YL; Chang EE; Chen HC
Biomed Pharmacother; 2020 Apr; 124():109892. PubMed ID: 31986415
[TBL] [Abstract][Full Text] [Related]
29. Basic fibroblast growth factor exhibits dual and rapid regulation of cyclin D1 and p27 to stimulate proliferation of rat cerebral cortical precursors.
Li B; DiCicco-Bloom E
Dev Neurosci; 2004; 26(2-4):197-207. PubMed ID: 15711060
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-7 stimulation inhibits nephrin activation and induces podocyte injury.
Zhai S; Zhao L; Zhang Y; Ma Q
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):100-105. PubMed ID: 30454893
[TBL] [Abstract][Full Text] [Related]
31. RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy.
Huang Z; Peng Y; Yu H; Yu X; Zhou J; Xiao J
Biochem Biophys Res Commun; 2018 Oct; 504(4):949-956. PubMed ID: 30220545
[TBL] [Abstract][Full Text] [Related]
32. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).
Sugimoto M; Martin N; Wilks DP; Tamai K; Huot TJ; Pantoja C; Okumura K; Serrano M; Hara E
Oncogene; 2002 Nov; 21(53):8067-74. PubMed ID: 12444543
[TBL] [Abstract][Full Text] [Related]
33. Ara-c induces cell cycle G1/S arrest by inducing upregulation of the INK4 family gene or directly inhibiting the formation of the cell cycle-dependent complex CDK4/cyclin D1.
Sun F; Li N; Tong X; Zeng J; He S; Gai T; Bai Y; Liu L; Lu K; Shen J; Han M; Lu C; Dai F
Cell Cycle; 2019 Sep; 18(18):2293-2306. PubMed ID: 31322047
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-206 and its down-regulation of Wilms'Tumor-1 dictate podocyte health in adriamycin-induced nephropathy.
Guo N; Guo J; Su D
Ren Fail; 2016 Jul; 38(6):989-95. PubMed ID: 27056206
[TBL] [Abstract][Full Text] [Related]
35. Cell-cell contact regulates gene expression in CDK4-transformed mouse podocytes.
Sakairi T; Abe Y; Jat PS; Kopp JB
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F802-9. PubMed ID: 20668098
[TBL] [Abstract][Full Text] [Related]
36. RN181 is a tumour suppressor in gastric cancer by regulation of the ERK/MAPK-cyclin D1/CDK4 pathway.
Wang S; Wang X; Gao Y; Peng Y; Dong N; Xie Q; Zhang X; Wu Y; Li M; Li JL
J Pathol; 2019 Jun; 248(2):204-216. PubMed ID: 30714150
[TBL] [Abstract][Full Text] [Related]
37. Nuclear YAP localization as a key regulator of podocyte function.
Bonse J; Wennmann DO; Kremerskothen J; Weide T; Michgehl U; Pavenstädt H; Vollenbröker B
Cell Death Dis; 2018 Aug; 9(9):850. PubMed ID: 30154411
[TBL] [Abstract][Full Text] [Related]
38. RhoA deficiency disrupts podocyte cytoskeleton and induces podocyte apoptosis by inhibiting YAP/dendrin signal.
Huang Z; Zhang L; Chen Y; Zhang H; Yu C; Zhou F; Zhang Z; Jiang L; Li R; Ma J; Li Z; Lai Y; Lin T; Zhao X; Zhang Q; Zhang B; Ye Z; Liu S; Wang W; Liang X; Liao R; Shi W
BMC Nephrol; 2016 Jul; 17(1):66. PubMed ID: 27389190
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effect of NBL1 on PDGF-BB-induced human PASMC proliferation through blockade of PDGFβ-p38MAPK pathway.
Cui C; Zhang H; Guo LN; Zhang X; Meng L; Pan X; Wei Y
Biosci Rep; 2016 Aug; 36(4):. PubMed ID: 27474499
[TBL] [Abstract][Full Text] [Related]
40. HMGB1 mediates IFN-γ-induced cell proliferation in MMC cells through regulation of cyclin D1/CDK4/p16 pathway.
Feng X; Hao J; Liu Q; Yang L; Lv X; Zhang Y; Xing L; Xu N; Liu S
J Cell Biochem; 2012 Jun; 113(6):2009-19. PubMed ID: 22275109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
